Efficacy of weekly docetaxel combined with platinum as 1st-line treatment in patients with advanced non-small cell lung cancer

被引：1
|
作者：
Lee, W. S. [1 ]
Bae, B. J. [2 ]
Ryoo, H. M. [3 ]
Bae, S. H. [3 ]
Lee, S. C. [3 ]
Hyun, D. S. [3 ]
机构：
[1] Taegu Fatima Hosp, Dept Internal Med, Taegu, South Korea
[2] Taegu Fatima Hosp, Dept Surg, Taegu, South Korea
[3] Taegu Catholic Univ Hosp, Dept Internal Med, Taegu, South Korea
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71447-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6619
引用
收藏
页码：393 / 393
页数：1
相关论文
共 50 条
  • [1] Factors affecting the efficacy and safety of docetaxel combined with platinum in the treatment of advanced non-small cell lung cancer
    Wang, FengLi
    Zhao, ChenYang
    Wen, Xin
    Zheng, Qingshan
    Li, Lujin
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (10) : 1295 - 1303
  • [2] Weekly Paclitaxel/Docetaxel Combined with a Platinum in the Treatment of Advanced Non-Small Cell Lung Cancer: a Study on Efficacy, Safety and Pre-medication
    Zhou, Jian-Nong
    Huang, Xin-En
    Ye, Zhuo
    Li, Chao
    Zhang, Qian
    Lin, Yong
    Jiang, Wei
    Sun, Wei-Li
    Shi, Mei-Qi
    Shu, Yong-Qian
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2009, 10 (06) : 1147 - 1150
  • [3] Weekly docetaxel as a second-line treatment for advanced non-small cell lung cancer (NSCLC).
    García, R
    Pérez, P
    Alfonso, R
    Pérez-Manga, G
    Díaz-Rubio, E
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 116 - 116
  • [4] Phase II study of carboplatin combined with weekly docetaxel in patients with advanced non-small cell lung cancer
    Jiang, Lian
    Wang, Dao-yuan
    Zhu, Zhi-hua
    Tang, Liang-fa
    Hou, Xin-heng
    Zhao, Hong-da
    Xie, Zheng
    Wang, Dan-feng
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (03) : 449 - 453
  • [5] Phase II study of carboplatin combined with weekly docetaxel in patients with advanced non-small cell lung cancer
    Lian Jiang
    Dao-yuan Wang
    Zhi-hua Zhu
    Liang-fa Tang
    Xin-heng Hou
    Hong-da Zhao
    Zheng Xie
    Dan-feng Wang
    [J]. Cancer Chemotherapy and Pharmacology, 2010, 66 : 449 - 453
  • [6] Erlotinib as 1st-line therapy for elderly patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Merimsky, O.
    Cheng, C.
    Reck, M.
    Au, S.
    von Pawel, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Weekly docetaxel and vinorelbine as second-line therapy in advanced non-small cell lung cancer
    Huber, R
    Schmidt, M
    Borgmeier, A
    [J]. LUNG CANCER, 2005, 49 : S248 - S248
  • [8] Efficacy and tolerability of a weekly schedule of docetaxel-cisplatin as first-line treatment for advanced non-small cell lung cancer (NSCLC)
    Binder, D.
    Hackenthal, M.
    Graseck, L.
    Schweisfurth, H.
    Schaeper, C.
    Kruell, M.
    Temmesfeld-Wollbrueck, B.
    Suttorp, N.
    Beinert, T.
    Hellriegel, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] A phase II study of weekly docetaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer
    Son, C.
    Kim, K.
    Lee, K.
    Yang, D.
    Lee, S.
    Choi, P.
    Cho, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Nedaplatin or Oxaliplatin Combined with Paclitaxel and Docetaxel as First-Line Treatment for Patients with Advanced Non-Small Cell Lung Cancer
    Zhang, Keqian
    Qin, Hong
    Pan, Feng
    Liu, Enqiang
    Liang, Houjie
    Ruan, Zhihua
    [J]. MEDICAL SCIENCE MONITOR, 2014, 20 : 2830 - 2836
12345